3-Butyn-1-yl(2alpha,3beta)2,3-dihydroxy-olean-12-en-28-oate

ID: ALA3086608

PubChem CID: 76313534

Max Phase: Preclinical

Molecular Formula: C34H52O4

Molecular Weight: 524.79

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCCOC(=O)[C@]12CCC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2

Standard InChI:  InChI=1S/C34H52O4/c1-9-10-19-38-28(37)34-17-15-29(2,3)20-23(34)22-11-12-26-31(6)21-24(35)27(36)30(4,5)25(31)13-14-33(26,8)32(22,7)16-18-34/h1,11,23-27,35-36H,10,12-21H2,2-8H3/t23-,24+,25-,26+,27-,31-,32+,33+,34-/m0/s1

Standard InChI Key:  ODBCWOLAUHFTGZ-LULZRBEKSA-N

Molfile:  

     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
    1.7599   -4.6377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7599   -3.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4702   -3.4006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4702   -5.0502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9449   -5.6806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9954   -5.7396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1890   -4.6377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9035   -5.0502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6139   -4.6377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6139   -3.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6139   -2.9882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3284   -3.4006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3284   -4.2254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0388   -3.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7575   -3.4006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3284   -2.5800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6139   -2.1634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9035   -2.5800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9035   -3.4006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1890   -3.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1890   -2.9882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0454   -5.0502    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9035   -4.2254    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.4490   -4.2165    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.0343   -3.0088    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.0388   -2.1634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7590   -2.5854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4754   -2.1733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4863   -1.3418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7661   -0.9239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0392   -1.3335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3331   -0.1852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3598   -0.3198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5618   -2.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7807   -3.5982    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1494   -2.2077    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0378   -3.3972    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5867   -3.8095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8066   -4.6133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6125   -4.8246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4995   -5.0572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  1  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  1
 10 12  1  0
 12 13  1  6
 12 14  1  0
 14 15  1  0
 15 27  1  0
 26 16  1  0
 12 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 10 19  1  0
 19 20  1  0
  3 20  1  0
  7 20  1  0
 20 21  1  1
  1 22  1  1
 19 23  1  6
  7 24  1  6
 26 25  1  1
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 30 33  1  0
 27 34  1  1
 34 35  1  0
 34 36  2  0
  2 37  1  6
 35 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  3  0
M  END

Associated Targets(Human)

8505C (583 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 524.79Molecular Weight (Monoisotopic): 524.3866AlogP: 6.69#Rotatable Bonds: 3
Polar Surface Area: 66.76Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.63CX Basic pKa: CX LogP: 6.18CX LogD: 6.18
Aromatic Rings: Heavy Atoms: 38QED Weighted: 0.19Np Likeness Score: 2.86

References

1. Siewert B, Pianowski E, Csuk R..  (2013)  Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.,  70  [PMID:24161703] [10.1016/j.ejmech.2013.10.016]
2. Schwarz S, Loesche A, Lucas SD, Sommerwerk S, Serbian I, Siewert B, Pianowski E, Csuk R..  (2015)  Converting maslinic acid into an effective inhibitor of acylcholinesterases.,  103  [PMID:26383128] [10.1016/j.ejmech.2015.09.007]

Source